The efficacy of first-line tyrosine kinase inhibitors combined with co-medications in Asian patients with EGFR mutation non-small cell lung cancer

Lignende værker

• Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD
  af: Su, Vincent Yi-Fong, et al.
  Udgivet: (2018)
• Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition
  af: Yen, Hsin-Yung, et al.
  Udgivet: (2015)
• Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap
  af: Su, Vincent Yi-Fong, et al.
  Udgivet: (2018)
• First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer
  af: Su, Po‐Lan, et al.
  Udgivet: (2020)
• Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis
  af: Chao, Shih-Hsuan, et al.
  Udgivet: (2020)